AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Getting fair treatment: Brazil faces new challenge in its fight against Big Pharma.(HIV AND AIDS)
Brazil has a success story to share with the world. It was the first developing country to provide free antiretroviral (ARV) drugs to its HIV-positive citizens, leading to a dramatic cut in AIDS deaths. By manufacturing its own cheap generic versions of branded medicines, it took on and defeated the big transnational drug companies.
[ILLUSTRATION OMITTED]
Dr Andre de Mello e Souza of the Pontifica Universidade Catolica do Rio de Janeiro played a pivotal role in developing Brazil's policy on HIV treatment. Its history of health activism started during the 1980s democratization process and led to healthcare being incorporated into the 1988 Constitution as the right of the citizen and the duty of the state.
'This was tremendously important,' he says. 'It gave the public a legal base to demand their right to treatment. In 1996 another law was passed to give people HIV treatment free of charge.'
Brazil's stand was controversial at the time. 'The World Health Organization, the World Bank, the Gates Foundation were all saying "look, you have scarce resources and you have to apply them where they are most cost-effective". They thought all the resources should be channelled towards prevention.' But Brazil's free-drugs policy proved to be surprisingly cost-effective. It made significant savings in hospitalization costs, saw 50 per cent fewer infections than the World Bank had predicted, and death rates from AIDS plummeted.
Brazil came under intense pressure from Big Pharma, who had hoped for huge profits from their drugs. They argued that Brazil was depriving them of income needed to fund further research and development. In reality, according to former UN Special Envoy for AIDS in Africa, Stephen Lewis, these claims were 'highly inflated'. Such drugs are often developed in the public sector, then simply bought up and patented by pharmaceutical companies for mass manufacture: 'The drug companies spend far more on marketing than on R&D. Big Pharma's ...
- BRAZIL: PROGRESSIVE AIDS PROGRAM UNDER ATTACK BY BIG PHARMA AND US TRADE...
- Newspaper article from: NotiSur - South American Political and Economic Affairs Flynn, Matthew May 25, 2001 700+ words
...The latest conflict between Brazil and the multinational companies...HIV-positive population, Brazil's Health Ministry has threatened...medication. In response, Big Pharma--large multinational pharmaceutical...governing intellectual property. Brazil has won international support...
- BIG PHARMA WANTS INDIA, BRAZIL OFF TRIPS WAIVER (as India and Brazil are some...
- News wire article from: Asia Africa Intelligence Wire July 28, 2003 700+ words
...companies in the US led by Pfizer have proposed that India and Brazil should be barred from using compulsory licensing (CL) rights...countries with insufficient or no manufacturing. India and Brazil are some of the countries capable of using paragraph 6.
- 'Big Pharma rushing to get foothold in emerging markets despite challenges.'.
- Press release article from: M2 Presswire March 12, 2008 700+ words
...2008-DATAMONITOR: 'Big Pharma rushing to get foothold...an extent in Russia, Brazil and Turkey. Nevertheless...drugs out of pocket and Big Pharma are there ready to bank...the most attention are Brazil, Russia, India, China...
- Big Pharma and AIDS: Act II: patents and the price of second-line...
- Magazine article from: Multinational Monitor Weissman, Robert March 1, 2007 700+ words
...developing world outside of Brazil were receiving lifesaving antiretroviral...provoked cries of protest from Big Pharma and threats of sanctions from...differently in one key country, Brazil. Under its constitution...the brand-name companies, Brazil sought to make ARVs domestically...
- Patent busting: getting up Big Pharma's nose in order to save lives.(CORPORATE...
- Magazine article from: New Internationalist Macan-Markar, Marwaan July 1, 2007 700+ words
...President Bill Clinton, the Government of Brazil and, most recently, the public health...defence of Thailand by mounting boycotts of Big Pharma and concerted media campaigns. They...to break patents on drugs produced by Big Pharma when faced with a national health crisis...
- The right fix? A WTO deal on drugs; Big Pharma takes its medicine.
- Magazine article from: Global Agenda August 28, 2003 700+ words
...every poor country can emulate Brazil's success, because not every...poorer countries (India, Brazil, South Africa and Kenya...generics (such as India and Brazil), the needs of potential...haven't. In response to Big Pharma's fears, America defied...
- Big Pharma rushing to get foothold in emerging markets, despite challenges.
- Newspaper article from: Pharma Marketletter March 31, 2008 700+ words
...to an extent, in Russia, Brazil and Turkey. Nevertheless...for drugs out of pocket and Big Pharma are there ready to bank on...attracted the most attention are Brazil, Russia, India, China and...over the last few years, and Brazil and Turkey's health care...
- Indian drug cos lock horns with big pharma MNCs.
- News wire article from: Asia Africa Intelligence Wire January 21, 2003 700+ words
...accused IFPMA and PhRMA - which represent research-driven big pharma MNCs - of 'mudslinging' at the Indian drug industry. The...African countries. India and like-minded countries like Brazil who can supply these medicines have resisted a US/EU move...
- Electile dysfunction: it's election season once again, and everybody's running...
- Magazine article from: Medical Marketing & Media Arnold, Matthew December 1, 2007 700+ words
...like more of the same. For all the talk about acquisitions, big pharma firms sitting on large cash piles might look to Pfizer's...countries IMS has dubbed "pharmerging markets." China, Brazil, Mexico, South Korea, India, Turkey and Russia will grow...
- Case studies of Big Pharma's sharp practice: Turf wars.(Health Hazard)
- Magazine article from: New Internationalist November 1, 2003 700+ words
...especially in Latin America. Patient groups in Brazil demanded that their public health services...expensive Novartis brand drug, Neoral. In Brazil, where there are 8,000 users of cyclosporine...which was commanding 'abusive prices' in Brazil. By July 2002 it looked as if Novartis...
Source: HighBeam Research, Getting fair treatment: Brazil faces new challenge in its fight...